Allopurinol, sold under the brand name Zyloprim and generics, is a medication used primarily to treat excess uric acid in the blood and its complications, including chronic gout.[1] It is a xanthine oxidase inhibitor which is administered orally.
It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.[2]
Starting at
1H-pyrazolo[3,4-d]pyrimidin-4(2H)-one |
Trade names | Zyloprim |
AHFS/Drugs.com | monograph |
MedlinePlus | a682673 |
Pregnancy category |
C(USA) |
Legal status |
UK: POM (Prescription only) US: ℞-only |
Routes of administration |
tablet (100, 300 mg) |
Bioavailability | 78±20% |
Protein binding | Negligible |
Metabolism | hepatic (80% oxypurinol, 10% allopurinol ribosides) |
Biological half-life | 2 h (oxypurinol 18-30 h) |
CAS Number | 315-30-0 |
ATC code | M04AA01 |
PubChem | CID: 2094 |
IUPHAR/BPS | 6795 |
DrugBank | DB00437 |
ChemSpider | 2010 |
UNII | 63CZ7GJN5I |
KEGG | D00224 |
ChEBI | CHEBI:40279 |
ChEMBL | CHEMBL1467 |
Formula | C5H4N4O |
Molecular mass | 136.112 g/mol |
SMILES[show] |
|
InChI[show] |